Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel stable thioarylation reagent patent CN110283141B. Mild conditions, high stability, cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110981900A reveals a novel nickel-catalyzed method for synthesizing 1,1-diyne compounds from terminal olefins, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104583174B reveals high-yield α-fluoroacrylate production. Enhance supply chain reliability and reduce manufacturing costs with this novel carbonylation method.
Novel Pd-catalyzed C-H halogenation patent CN110563641B offers cost-effective synthesis for Lonafanib intermediates with enhanced supply chain reliability.
Patent CN115851863B reveals enzymatic route for spongane skeletons. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN114085152A reveals a green, high-yield route for 2-(4-nitrophenyl)butyric acid, eliminating nitration isomers for cost-effective API manufacturing.
Patent CN1419538A details a novel catalytic process for aromatic isocyanates, offering significant cost reduction and supply chain reliability for fine chemical intermediates manufacturing.
Novel patent CN118063427A reveals efficient synthesis route for herbicide intermediates. Offers significant cost reduction and supply chain reliability for global agrochemical manufacturers.
Patent CN112851508A details a safe, scalable route to 3,4-difluoro-2-methylbenzoic acid, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel NHC-catalyzed desymmetrization route for high-purity rolipram intermediates offering significant cost and supply chain advantages.
Patent CN114149475B reveals a novel two-step Azvudine synthesis avoiding phosphorus oxychloride, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel electrophilic thioarylation reagent synthesis via mild conditions. High stability reagent for pharmaceutical intermediates manufacturing cost reduction.
Novel patent CN110461840A enables robust manufacturing of asthma drug intermediates with reduced steps and enhanced supply chain reliability for global procurement.
Patent CN109678900B reveals a high-yield ionic liquid catalyzed route for phosphonate sulfonamides, offering significant cost reduction in pharmaceutical manufacturing and superior activity against MRSA.
Novel Lewis acid catalyzed synthesis reduces reaction time significantly. High yield pharmaceutical intermediate production with scalable supply chain reliability for global partners.
Patent CN85104009A details a safer, high-yield route for vinyl imidazole derivatives, offering significant cost reduction in pharmaceutical manufacturing and improved supply chain reliability.
Patent CN1775764A details a high-yield tetrazole synthesis using Yb(OTf)3. This method offers significant cost reduction in API manufacturing and improved supply chain reliability.
Novel one-pot synthesis of N-Boc-N-methyl-4-aminostyrene via methylation-elimination. High yield, low cost alternative for PET imaging intermediates.
Patent CN1150159C details a stable synthesis route for allyl quinone derivatives, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN104193629B reveals magnesium-catalyzed solvent-free synthesis. Delivers high-purity L-tert-leucine with significant supply chain and cost advantages.